or Try an Advanced Search...

    Treatment Of Acute Myeloid Leukemia Stocks List

    Symbol Grade Name % Change
    PYXS C Pyxis Oncology, Inc. -1.99
    APTO D Aptose Biosciences, Inc. -2.68
    FBIO F Fortress Biotech, Inc. -2.27
    SLS F SELLAS Life Sciences Group, Inc. 0.00
    BLRX F BioLineRx Ltd. -0.35
    CGEM F Cullinan Management, Inc. -5.46
    HCWB F HCW Biologics Inc. -1.74
    TCBP F TC BioPharm (Holdings) plc -1.69
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Acute Myeloid Leukemia Clinical Medicine Biopharmaceutical Cancer Medicine Solid Tumors Biotechnology Immunotherapy Cancer Treatment Immune System Immunology Immunotherapies Oncology Antineoplastic Drugs Autoimmune Disease Cancer Immunotherapy Cell Therapy Clinical Development Hematologic Malignancies Monoclonal Antibody

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Acute Myeloid Leukemia stocks.

    Symbol Grade Name Weight
    CNCR B Loncar Cancer Immunotherapy ETF 1.27
    CANC C Tema Oncology ETF 0.83
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 0.58
    HAPS A Harbor Corporate Culture Small Cap ETF 0.27
    XBI A SPDR S&P Biotech ETF 0.27
    View all Treatment Of Acute Myeloid Leukemia ETFs...
    Compare ETFs
    Compare BBC to XBI Compare CANC to HAPS Compare CANC to XBI

        Treatment Of Acute Myeloid Leukemia Stocks Recent News

        Date Stock Title
        Nov 7 CGEM Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
        Nov 5 SLS SELLAS Life Sciences to Present at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition 2024
        Nov 5 BLRX BioLineRx Announces Oral Presentation on Data from Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease at ASH 2024
        Nov 5 CGEM Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
        Nov 4 CGEM Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024
        Related Industries: Biotechnology
        Related Stock Lists: Acute Myeloid Leukemia Clinical Medicine Biopharmaceutical Cancer Medicine Solid Tumors Biotechnology Immunotherapy Cancer Treatment Immune System Immunology Immunotherapies Oncology Antineoplastic Drugs Autoimmune Disease Cancer Immunotherapy Cell Therapy Clinical Development Hematologic Malignancies Monoclonal Antibody
        Treatment Of Acute Myeloid Leukemia

        Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow. Treatment for AML typically involves chemotherapy, radiation therapy, and/or stem cell transplantation. Depending on the type of AML, other treatments such as targeted therapy, immunotherapy, and/or clinical trials may also be recommended.

        Browse All Tags